Company / Capital Expenditures
SOLENO THERAPEUTICS INC Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$73.0K
FY2025
5-year range
$0 / $218.0K
FY2021-FY2025
Trend
-66.5%
vs FY2024
Sector context
#169 of 192
Health Care
What the data says
SOLENO THERAPEUTICS INC's capital expenditures of $73,000 is lower than 88% of companies in the Health Care sector (FY2025). Capital Expenditures has fluctuated over the past 10 years, ranging from $0 in FY2023 to $218,000 in FY2024.
Based on SEC 10-K filings.
$73,000 in FY2025 with a 5-year CAGR of +59.8%.
Improved from $0 to $73,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +77.7%
- 5-Year CAGR
- +59.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 192This company $73.0K Sector average $118.6M
▼
-99.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +59.8%, indicating consistent growth.
- In FY2025, capital expenditures decreased 66.5% year-over-year.
- Ranks #169 out of 192 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $73.0K | -66.5% |
| FY2024 | $218.0K | - |
| FY2023 | $0 | -100.0% |
| FY2022 | $13.0K | -40.9% |
| FY2021 | $22.0K | +214.3% |
| FY2020 | $7.0K | -66.7% |
| FY2019 | $21.0K | +162.5% |
| FY2018 | $8.0K | +300.0% |
| FY2017 | $2.0K | -86.5% |
| FY2016 | $14.8K | -73.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026